PMC:7441788 / 6527-6800 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T22","span":{"begin":195,"end":199},"obj":"Body_part"},{"id":"T23","span":{"begin":260,"end":265},"obj":"Body_part"}],"attributes":[{"id":"A22","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A23","pred":"fma_id","subj":"T23","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T56","span":{"begin":100,"end":108},"obj":"Disease"},{"id":"T57","span":{"begin":229,"end":237},"obj":"Disease"},{"id":"T58","span":{"begin":240,"end":249},"obj":"Disease"}],"attributes":[{"id":"A56","pred":"mondo_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A57","pred":"mondo_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A58","pred":"mondo_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T63","span":{"begin":111,"end":119},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T64","span":{"begin":195,"end":199},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T65","span":{"begin":253,"end":265},"obj":"http://purl.obolibrary.org/obo/CLO_0051719"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T78","span":{"begin":123,"end":125},"obj":"Chemical"}],"attributes":[{"id":"A78","pred":"chebi_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-sample-CHEBI","denotations":[{"id":"T53","span":{"begin":123,"end":125},"obj":"Chemical"}],"attributes":[{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_3638"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T62","span":{"begin":100,"end":110},"obj":"Species"},{"id":"T63","span":{"begin":229,"end":239},"obj":"Species"}],"attributes":[{"id":"A62","pred":"ncbi_taxonomy_id","subj":"T62","obj":"NCBItxid:2697049"},{"id":"A63","pred":"ncbi_taxonomy_id","subj":"T63","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-sample-sentences","denotations":[{"id":"T53","span":{"begin":63,"end":168},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"292","span":{"begin":100,"end":110},"obj":"Species"},{"id":"300","span":{"begin":24,"end":27},"obj":"Chemical"},{"id":"301","span":{"begin":123,"end":125},"obj":"Chemical"},{"id":"302","span":{"begin":155,"end":158},"obj":"Chemical"},{"id":"307","span":{"begin":234,"end":249},"obj":"Disease"},{"id":"310","span":{"begin":253,"end":259},"obj":"CellLine"}],"attributes":[{"id":"A292","pred":"pubann:denotes","subj":"292","obj":"Tax:2697049"},{"id":"A300","pred":"pubann:denotes","subj":"300","obj":"MESH:D006886"},{"id":"A301","pred":"pubann:denotes","subj":"301","obj":"MESH:D002738"},{"id":"A302","pred":"pubann:denotes","subj":"302","obj":"MESH:D006886"},{"id":"A307","pred":"pubann:denotes","subj":"307","obj":"MESH:C000657245"},{"id":"A310","pred":"pubann:denotes","subj":"310","obj":"CVCL:0574"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T51","span":{"begin":195,"end":199},"obj":"http://purl.obolibrary.org/obo/CL_0000000"},{"id":"T52","span":{"begin":240,"end":249},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"},{"id":"T53","span":{"begin":260,"end":265},"obj":"http://purl.obolibrary.org/obo/CL_0000000"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-sample-PD-FMA","denotations":[{"id":"T22","span":{"begin":195,"end":199},"obj":"Body_part"},{"id":"T23","span":{"begin":260,"end":265},"obj":"Body_part"}],"attributes":[{"id":"A22","pred":"fma_id","subj":"T22","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A23","pred":"fma_id","subj":"T23","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T49","span":{"begin":100,"end":110},"obj":"Disease"},{"id":"T50","span":{"begin":229,"end":239},"obj":"Disease"},{"id":"T51","span":{"begin":240,"end":249},"obj":"Disease"}],"attributes":[{"id":"A49","pred":"mondo_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A50","pred":"mondo_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A51","pred":"mondo_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-PubTator","denotations":[{"id":"292","span":{"begin":100,"end":110},"obj":"Species"},{"id":"300","span":{"begin":24,"end":27},"obj":"Chemical"},{"id":"301","span":{"begin":123,"end":125},"obj":"Chemical"},{"id":"302","span":{"begin":155,"end":158},"obj":"Chemical"},{"id":"307","span":{"begin":234,"end":249},"obj":"Disease"},{"id":"310","span":{"begin":253,"end":259},"obj":"CellLine"}],"attributes":[{"id":"A292","pred":"tao:has_database_id","subj":"292","obj":"Tax:2697049"},{"id":"A300","pred":"tao:has_database_id","subj":"300","obj":"MESH:D006886"},{"id":"A301","pred":"tao:has_database_id","subj":"301","obj":"MESH:D002738"},{"id":"A302","pred":"tao:has_database_id","subj":"302","obj":"MESH:D006886"},{"id":"A307","pred":"tao:has_database_id","subj":"307","obj":"MESH:C000657245"},{"id":"A310","pred":"tao:has_database_id","subj":"310","obj":"CVCL:0574"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"LitCovid-sentences","denotations":[{"id":"T53","span":{"begin":63,"end":168},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}

{"project":"2_test","denotations":[{"id":"32496926-32194981-132195665","span":{"begin":58,"end":60},"obj":"32194981"}],"text":"tly higher than that of HCQ (55.32, 61.45, 14.41, 19.25) [17]. These results indicate that the anti-SARS-CoV-2 activity of CQ seems to be more potent than HCQ in vitro. However, another in vitro cell experiment showed that after SARS-CoV-2 infection of VeroE6 cells, the EC"}